Peptides and Autoimmune Conditions: What the Research Shows
An evidence-based review of peptide research in autoimmune and inflammatory conditions. Covers Thymosin Alpha-1 (Treg modulation, hepatitis trials), BPC-157 (gut-immune axis, IBD models), KPV (NF-κB inhibition, PepT1 uptake), LL-37 (innate immune regulation), and Selank (neuroimmune axis) — with a research framework for matching peptides to specific autoimmune models.
